Trial Profile
Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Feb 2015
Price :
$35
*
At a glance
- Drugs Tegaserod (Primary)
- Indications Non-ulcer dyspepsia
- Focus Registrational; Therapeutic Use
- Sponsors Novartis
- 06 Nov 2005 New trial record.